Literature DB >> 32146921

COVID-19 and gender-specific difference: Analysis of public surveillance data in Hong Kong and Shenzhen, China, from January 10 to February 15, 2020.

Shi Zhao1,2, Peihua Cao3, Marc K C Chong1,2, Daozhou Gao4, Yijun Lou5, Jinjun Ran6, Kai Wang7, Weiming Wang8, Lin Yang9, Daihai He5, Maggie H Wang1,2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32146921      PMCID: PMC7113032          DOI: 10.1017/ice.2020.64

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


× No keyword cloud information.
To the Editor—An outbreak of coronavirus disease (COVID-19), which began in Wuhan, China in the end of 2019,[1] has now reached over 100 countries and poses a huge threat to the global public health and economy.[2] Given the risk of human-to-human transmission, the serial interval, which refers to the time interval from symptom onset of a primary case (ie, the infector) to that of a secondary case (ie, the infectee),[3] is an essential quantity, in addition to the basic reproduction number, that drives the speed of spread. We examined the publicly available materials and collected the records of COVID-19 transmission events in 2 neighboring large cities, Hong Kong[4] and Shenzhen,[5] in south China from January 10 to February 15, 2020, and we extracted the serial interval data. We identified 48 transmission events (21 in Hong Kong and 27 in Shenzhen), among which 40 events contained the gender information of the primary cases. The last onset date of the primary cases among all collected transmission events was February 2, 2020. The data were collected via public domain; thus, neither ethical approval nor individual consent was applicable. All data used in this work were publicly available from press releases from the Centre for Health Protection (CHP) of Hong Kong[4] and the COVID-19 outbreak situation reports of the Shenzhen Municipal Health Commission,[5] and the key R code is provided as a supplementary file online. To explore the temporal patterns and the gender-specific difference of serial intervals, we adopted two regression models. Model 1 is a log-linear form for the percentage change, E[ln(SI)] = α 1 G + α 2 t + α 0, and model 2 is a linear form for the unit change, E[SI] = β 1 G + β 2 t + β 0, where E[·] is the expectation and α and β are the regression coefficients. The SI represents the serial interval of the ith primary case whose onset date is the tth day. G denotes the gender of the ith primary case. Hence, the [exp(α 2) – 1] × 100% quantifies the percentage change, and β 2 quantifies the unit change (day) in the serial interval, namely change per day in the calendar date. The gender-specific difference can be interpreted similarly. We fit both models using the standard least-squares approach. As shown in Figure 1, the serial interval decreased by 0.4 (95% CI, 0.1−0.7), or 6.2% per day (95% CI, 0.4%−11.6%) from January 10 to February 2 in Hong Kong and Shenzhen. The Pearson correlation coefficient between the serial interval and calendar date is estimated at −0.37 (P < .01). The serial interval of male primary cases was 3.5 days (95% CI, 1.2−5.7) shorter than that of female primary cases, or 49.7% (95% CI, 15.3−70.1%) lower in percentage. To verify this finding, we additionally conducted a Cox proportional hazard modeling analysis using a similar formula as in models 1 and 2 to calculate the hazard ratio estimates. The association between serial interval and calendar date as well as gender-specific difference held consistently and significantly.
Fig. 1.

The observed (dots and bars) and fitted (curves) serial interval of COVID-19. The results of model (1) are shown in panel (a), and those of model (2) are shown in panel (b). In both panels, the red represents the female primary cases, and the blue represents the male primary cases. The dots are the observed (or median) serial interval, and the bars are the ranges of serial intervals for multiple primary cases. The bold curves are the fitting results and the dashed curves are the 95% confidence intervals.

The observed (dots and bars) and fitted (curves) serial interval of COVID-19. The results of model (1) are shown in panel (a), and those of model (2) are shown in panel (b). In both panels, the red represents the female primary cases, and the blue represents the male primary cases. The dots are the observed (or median) serial interval, and the bars are the ranges of serial intervals for multiple primary cases. The bold curves are the fitting results and the dashed curves are the 95% confidence intervals. The shortening in serial interval over time is likely due to the strengthening of the public health control measures. The contact tracing and timely isolation of confirmed COVID-19 infections could lead to shorter observed serial interval due to right censoring ‘bias’.[6,7] As such, we call the observed serial interval under the effects of control measures the effective serial interval, which has a mean of 5.2 days from our data set. This result appears slightly but not significantly shorter than the previous estimated ‘intrinsic’ serial interval, with a mean of 7.5 days.[1] The mechanism behind the gender difference remains unknown, but it may be partly due to the fact that male cases are more severe than female cases (ie, “officials recorded a 2.8% fatality rate for male patients versus 1.7% for female patients”[8]). The findings regarding the serial intervals of COVID-19 in Hong Kong and Shenzhen, and their implications, warrant further investigation.
  4 in total

1.  [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China].

Authors: 
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2020-02-10

2.  The interval between successive cases of an infectious disease.

Authors:  Paul E M Fine
Journal:  Am J Epidemiol       Date:  2003-12-01       Impact factor: 4.897

3.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Authors:  Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 176.079

4.  Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study.

Authors:  Joseph T Wu; Kathy Leung; Gabriel M Leung
Journal:  Lancet       Date:  2020-01-31       Impact factor: 79.321

  4 in total
  20 in total

1.  Role of neutrophil-lymphocyte-ratio in the mortality of males diagnosed with COVID-19.

Authors:  Tahir Belice; Ismail Demir; Arif Yüksel
Journal:  Iran J Microbiol       Date:  2020-06

Review 2.  Vitamin D and COVID-19: Role of ACE2, age, gender, and ethnicity.

Authors:  Bruk Getachew; Yousef Tizabi
Journal:  J Med Virol       Date:  2021-05-19       Impact factor: 20.693

3.  Epidemiological characteristics and spatial-temporal analysis of COVID-19 in Shandong Province, China.

Authors:  C Qi; Y C Zhu; C Y Li; Y C Hu; L L Liu; D D Zhang; X Wang; K L She; Y Jia; T X Liu; X J Li
Journal:  Epidemiol Infect       Date:  2020-07-06       Impact factor: 2.451

4.  Application and effects of fever screening system in the prevention of nosocomial infection in the only designated hospital of coronavirus disease 2019 (COVID-19) in Shenzhen, China.

Authors:  Ting Huang; Yinsheng Guo; Shaxi Li; Yanqun Zheng; Lin Lei; Xianhu Zeng; Qiao Zhong; Yingxia Liu; Lei Liu
Journal:  Infect Control Hosp Epidemiol       Date:  2020-04-13       Impact factor: 3.254

Review 5.  Impact of sex and gender on COVID-19 outcomes in Europe.

Authors:  Catherine Gebhard; Vera Regitz-Zagrosek; Hannelore K Neuhauser; Rosemary Morgan; Sabra L Klein
Journal:  Biol Sex Differ       Date:  2020-05-25       Impact factor: 5.027

Review 6.  Rapid review of available evidence on the serial interval and generation time of COVID-19.

Authors:  John Griffin; Miriam Casey; Áine Collins; Kevin Hunt; David McEvoy; Andrew Byrne; Conor McAloon; Ann Barber; Elizabeth Ann Lane; SImon More
Journal:  BMJ Open       Date:  2020-11-23       Impact factor: 2.692

7.  Clinical Suspicion of COVID-19 in Nursing Home Residents: Symptoms and Mortality Risk Factors.

Authors:  Jeanine J S Rutten; Anouk M van Loon; Janine van Kooten; Laura W van Buul; Karlijn J Joling; Martin Smalbrugge; Cees M P M Hertogh
Journal:  J Am Med Dir Assoc       Date:  2020-10-28       Impact factor: 4.669

8.  A novel IDEA: The impact of serial interval on a modified-Incidence Decay and Exponential Adjustment (m-IDEA) model for projections of daily COVID-19 cases.

Authors:  Ben A Smith
Journal:  Infect Dis Model       Date:  2020-05-30

Review 9.  Gender medicine: Lessons from COVID-19 and other medical conditions for designing health policy.

Authors:  Yossy Machluf; Yoram Chaiter; Orna Tal
Journal:  World J Clin Cases       Date:  2020-09-06       Impact factor: 1.337

10.  Sex differences in COVID-19 course and outcome: progesterone should not be neglected.

Authors:  Hrvoje Jakovac
Journal:  J Appl Physiol (1985)       Date:  2020-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.